CYTODYN INC (CYDY) SEC filings
CYDY SEC filings moved a median of -0.55% by the close. CYDY SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the CYDY overview →
62 measured CYDY SEC filing events.
Where these CYDY SEC filings landedvs 62 measured CYDY SEC filing reactions
| Middle 50% of CYDY SEC filing reactions | -3.73% to +0.76% |
|---|---|
| Median reaction (to close) | -0.55% |
| Measured reactions | 62 |
Point-in-time · zero look-ahead
Half of the 62 CYDY SEC filing events with a measured close landed between -3.73% and +0.76%; 42% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q CytoDyn Inc. For: Aug 31 | SEC filing · Form 10-Q | +1.01% | +1.01% | |
| Form EFFECT CytoDyn Inc. | SEC filing · Form EFFECT | +0.90% | +0.65% | |
| Form EFFECT CytoDyn Inc. | SEC filing · Form EFFECT | -1.50% | +0.00% | |
| Form DEF 14A CytoDyn Inc. For: Sep 28 | SEC filing · Form DEF | +4.46% | -4.08% | |
| Form POS AM CytoDyn Inc. | SEC filing · Form POS | -1.57% | +0.06% | |
| Form S-3 CytoDyn Inc. | SEC filing · Form S-3 | -1.57% | +0.06% | |
| Form 10-K CytoDyn Inc. For: May 31 | SEC filing · Form 10-K | +0.00% | +5.20% | |
| Form EFFECT CytoDyn Inc. | SEC filing · Form EFFECT | -1.20% | -3.14% | |
| Form D CytoDyn Inc. | SEC filing · Form D | +3.65% | -0.62% | |
| Form 8-K CytoDyn Inc. For: Apr 30 | SEC filing · Form 8-K | +2.95% | +0.62% | |
| Form S-1 CytoDyn Inc. | SEC filing · Form S-1 | -1.74% | -12.98% | |
| Form 10-Q CytoDyn Inc. For: Feb 28 | SEC filing · Form 10-Q | -0.48% | +3.95% | |
| Form 8-K CytoDyn Inc. For: Mar 24 | SEC filing · Form 8-K | +1.34% | +0.65% | |
| Form 8-K CytoDyn Inc. For: Feb 27 | SEC filing · Form 8-K | +0.88% | -1.83% | |
| Form 10-Q CytoDyn Inc. For: Nov 30 | SEC filing · Form 10-Q | +0.00% | -3.54% | |
| Form EFFECT CytoDyn Inc. | SEC filing · Form EFFECT | +1.89% | -0.86% | |
| Form POS AM CytoDyn Inc. | SEC filing · Form POS | +0.82% | +2.23% | |
| Form EFFECT CytoDyn Inc. | SEC filing · Form EFFECT | -0.88% | -3.51% | |
| Form 8-K CytoDyn Inc. For: Nov 23 | SEC filing · Form 8-K | -3.32% | -3.79% | |
| Form 8-K CytoDyn Inc. For: Nov 21 | SEC filing · Form 8-K | +2.40% | +9.62% | |
| Form S-3 CytoDyn Inc. | SEC filing · Form S-3 | +4.13% | +2.08% | |
| Form 8-K CytoDyn Inc. For: Nov 03 | SEC filing · Form 8-K | -3.89% | +0.04% | |
| Form DEFA14A CytoDyn Inc. | SEC filing · Form DEFA14A | -0.18% | -6.59% | |
| Form 10-Q CytoDyn Inc. For: Aug 31 | SEC filing · Form 10-Q | +0.00% | +2.97% | |
| Form DEFA14A CytoDyn Inc. | SEC filing · Form DEFA14A | +3.56% | +3.87% | |
| Form DEF 14A CytoDyn Inc. For: Nov 21 | SEC filing · Form DEF | -1.92% | +0.00% | |
| Form PRE 14A CytoDyn Inc. For: Nov 21 | SEC filing · Form PRE | -4.25% | +7.20% | |
| Form EFFECT CytoDyn Inc. | SEC filing · Form EFFECT | +0.00% | -1.00% | |
| Form 10-K CytoDyn Inc. For: May 31 | SEC filing · Form 10-K | -9.06% | -11.13% | |
| Form S-3 CytoDyn Inc. | SEC filing · Form S-3 | -9.06% | -11.13% | |
| Form 8-K CytoDyn Inc. For: May 14 | SEC filing · Form 8-K | -1.29% | -2.00% | |
| Form 8-K CytoDyn Inc. For: May 02 | SEC filing · Form 8-K | -7.69% | -17.41% | |
| Form 10-Q CytoDyn Inc. For: Feb 28 | SEC filing · Form 10-Q | -3.81% | +0.00% | |
| Form 10-Q CytoDyn Inc. For: Nov 30 | SEC filing · Form 10-Q | +0.33% | -0.67% | |
| Form 8-K CytoDyn Inc. For: Nov 22 | SEC filing · Form 8-K | +3.63% | +2.42% | |
| Form 10-Q CytoDyn Inc. For: Aug 31 | SEC filing · Form 10-Q | -1.54% | -0.94% | |
| Form DEF 14A CytoDyn Inc. For: Nov 22 | SEC filing · Form DEF | -1.75% | +0.74% | |
| Form EFFECT CytoDyn Inc. | SEC filing · Form EFFECT | +0.59% | -3.27% | |
| Form 10-K/A CytoDyn Inc. For: May 31 | SEC filing · Form 10-K | -1.24% | -3.29% | |
| Form EFFECT CytoDyn Inc. | SEC filing · Form EFFECT | +0.00% | +0.00% | |
| Form POS AM CytoDyn Inc. | SEC filing · Form POS | +1.27% | -1.90% | |
| Form S-1 CytoDyn Inc. | SEC filing · Form S-1 | +1.27% | -1.90% | |
| Form 10-K CytoDyn Inc. For: May 31 | SEC filing · Form 10-K | +0.00% | +2.05% | |
| Form 8-K CytoDyn Inc. For: Jul 02 | SEC filing · Form 8-K | +2.93% | +4.12% | |
| Form 8-K CytoDyn Inc. For: Jun 28 | SEC filing · Form 8-K | +2.19% | +0.44% | |
| Form 8-K CytoDyn Inc. For: May 28 | SEC filing · Form 8-K | +5.48% | +0.69% | |
| Form 8-K CytoDyn Inc. For: May 06 | SEC filing · Form 8-K | -5.35% | -5.93% | |
| Form 10-Q CytoDyn Inc. For: Feb 29 | SEC filing · Form 10-Q | +2.07% | +2.07% | |
| Form 8-K CytoDyn Inc. For: Apr 03 | SEC filing · Form 8-K | +0.27% | +1.21% | |
| Form 8-K CytoDyn Inc. For: Mar 22 | SEC filing · Form 8-K | +0.49% | +0.77% | |
| Form EFFECT CytoDyn Inc. | SEC filing · Form EFFECT | -2.92% | -2.87% | |
| Form S-1 CytoDyn Inc. | SEC filing · Form S-1 | -3.90% | -4.15% | |
| Form 8-K CytoDyn Inc. For: Jan 23 | SEC filing · Form 8-K | -0.94% | +3.55% | |
| Form 10-Q CytoDyn Inc. For: Nov 30 | SEC filing · Form 10-Q | +1.94% | -5.66% | |
| Form 8-K CytoDyn Inc. For: Dec 19 | SEC filing · Form 8-K | -4.05% | -9.64% | |
| Form 8-K CytoDyn Inc. For: Dec 14 | SEC filing · Form 8-K | +12.23% | -11.29% | |
| Form 8-K CytoDyn Inc. For: Nov 21 | SEC filing · Form 8-K | -1.15% | -7.76% | |
| Form 8-K CytoDyn Inc. For: Nov 17 | SEC filing · Form 8-K | -0.77% | +0.39% | |
| Form 8-K CytoDyn Inc. For: Nov 09 | SEC filing · Form 8-K | — | -0.48% | |
| Form 8-K CytoDyn Inc. For: Nov 03 | SEC filing · Form 8-K | -2.35% | -4.12% | |
| Form DEFA14A CytoDyn Inc. | SEC filing · Form DEFA14A | -2.35% | -4.12% | |
| Form 10-Q CytoDyn Inc. For: Aug 31 | SEC filing · Form 10-Q | -5.88% | -5.88% |
Keep exploring
More CYDY: earnings → · analyst actions → · CYDY overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Arbutus Biopharma Corporation (ABUS) | 191 | +0.11% | 52% |
| BeiGene, Ltd. - American Depositary Shares (BGNE) | 191 | +0.11% | 52% |
| BAVARIAN NORDIC R/I S/ADR (BVNRY) | 190 | 0.00% | 29% |
| U S STEM CELL INC (USRM) | 190 | 0.00% | 37% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.